Ibuprofen And Famotidine
Pricing Report NDC 70748-312-09

Latest NADAC: $0.87981 per EA · Effective Apr 23, 2025 · Est. package price $79.18 (90 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Ibuprofen And Famotidine (NDC 70748-312-09) is $0.87981 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 23, 2025.

As a provided by Lupin Pharmaceuticals, Inc., this medication is distributed in a 90 TABLET, COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.87981
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 23, 2025
Billable Units
90 EA
Estimated Package Price
$79.18
Data Status
As of May 14, 2025
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
70748-312-09
Description
90 TABLET, COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2022, the NADAC wholesale price for (NDC ) has moved within a range of $0.85162 to $4.16641 per EA. Over this 3 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8516 - $4.1664
Market Volatility
389.23% Variance
Latest Trend
0.46%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Apr 23, 2025 $0.87981 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $0.87581 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $0.85162 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $0.97629 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $1.11910 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $1.23728 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $1.33094 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $1.44791 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2024 $1.30891 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2024 $1.67498 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $1.60154 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $1.54393 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026